ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Final NICE yes for Amicus’ Fabry disease drug
pharmatimes
February 23, 2017Cost regulators for NHS therapies in England and Wales have now published final guidelines endorsing the use of Amicus Therapeutics' Galafold for treating the rare genetic disorder Fabry disease.
Pharma Sources Insight July 2025
